A5088165245- Influenza Virus Research Studies
- Respiratory viral infections research
- Antimicrobial Resistance in Staphylococcus
- COVID-19 epidemiological studies
- Viral Infections and Outbreaks Research
- Animal Disease Management and Epidemiology
- Bacterial Identification and Susceptibility Testing
- Viral gastroenteritis research and epidemiology
- Pneumonia and Respiratory Infections
- Viral Infections and Vectors
- Streptococcal Infections and Treatments
- Nosocomial Infections in ICU
- Bacillus and Francisella bacterial research
- Data-Driven Disease Surveillance
- Antibiotic Resistance in Bacteria
- SARS-CoV-2 and COVID-19 Research
- Legionella and Acanthamoeba research
- Bacterial biofilms and quorum sensing
- Antibiotic Use and Resistance
- Disaster Response and Management
- Smoking Behavior and Cessation
- Vibrio bacteria research studies
- Clostridium difficile and Clostridium perfringens research
- Zoonotic diseases and public health
- Travel-related health issues
Centers for Disease Control and Prevention
2014-2025
National Center for Immunization and Respiratory Diseases
2013-2024
National Center for Emerging and Zoonotic Infectious Diseases
2023-2024
National Influenza Center
2010-2022
World Health Organization
2022
Centers for Disease Control and Prevention
2017-2022
Battelle
2018-2020
Computer Emergency Response Team
2020
Response Biomedical (Canada)
2020
Biomedical Advanced Research and Development Authority
2018
Generation of Swine Flu As the newly emerged influenza virus starts its journey to infect world's human population, genetic secrets 2009 outbreak swine A(H1N1) are being revealed. In extensive phylogenetic analyses, Garten et al. (p. 197 , published online 22 May) confirm that eight elements virus, basic components encoded by hemagglutinin, nucleoprotein, and nonstructural genes originated in birds transferred pigs 1918. Subsequently, these formed a triple reassortant with RNA polymerase PB1...
This report updates the 2013 recommendations by Advisory Committee on Immunization Practices (ACIP) regarding use of seasonal influenza vaccines. Updated information for 2014-15 season includes 1) antigenic composition U.S. vaccines; 2) vaccine dose considerations children aged 6 months through 8 years; and 3) a preference use, when immediately available, live attenuated (LAIV) healthy 2 years, to be implemented as feasible but not later than 2015-16 season. Information issues related...
Methicillin-resistant Staphylococcus aureus (MRSA) is an emerging cause of infections outside health care settings. We investigated outbreak abscesses due to MRSA among members a professional football team and examined the transmission microbiologic characteristics strain.We conducted retrospective cohort study nasal-swab survey 84 St. Louis Rams players staff members. S. recovered from wound, nasal, environmental cultures was analyzed by means pulsed-field gel electrophoresis (PFGE) typing...
US hospital discharges for which Clostridium difficile-associated disease (CDAD) was listed as any diagnosis doubled from 82,000 (95% confidence interval [CI] 71,000-94,000) or 31/100,000 population in 1996 to 178,000 CI 151,000-205,000) 61/100,000 2003; this increase significant between 2000 and 2003 (slope of linear trend 9.48; 95% 6.16-12.80, p = 0.01). The overall rate during period severalfold higher persons >65 years age (228/100,000) than the group with next highest rate, 45-64...
In October 2001, the first inhalational anthrax case in United States since 1976 was identified a media company worker Florida. A national investigation initiated to identify additional cases and determine possible exposures Bacillus anthracis. Surveillance enhanced through health-care facilities, laboratories, other means cases, which were defined as clinically compatible illness with laboratory-confirmed B. anthracis infection. From 4 November 20, 22 of (11 inhalational, 11 cutaneous)...
In August 2002, fever and mental-status changes developed in recipients of organs from a common donor. Transmission West Nile virus through organ transplantation was suspected.
Abstract US hospital discharges for which Clostridium difficile–associated disease (CDAD) was listed as any diagnosis doubled from 82,000 (95% confidence interval [CI] 71,000–94,000) or 31/100,000 population in 1996 to 178,000 CI 151,000–205,000) 61/100,000 2003; this increase significant between 2000 and 2003 (slope of linear trend 9.48; 95% 6.16–12.80, p = 0.01). The overall rate during period severalfold higher persons >65 years age (228/100,000) than the group with next highest rate,...
Objective. To provide consensus recommendations for the management of acute otitis media (AOM) and surveillance drug-resistant Streptococcus pneumoniae (DRSP). Five questions were addressed: (1) Can amoxicillin remain best initial antimicrobial agent treating AOM in current period increasing prevalence DRSP? (2) What are suitable alternative agents use if fails? (3) Should empiric treatment vary by geographic region? (4) Where can clinicians learn about resistance patterns their patient...
In December 2003 and April 2005, signs symptoms suggestive of infection developed in two groups recipients solid-organ transplants. Each cluster was investigated because diagnostic evaluations were unrevealing, each a common donor recognized.
This report from CDC's Morbidity and Mortality Weekly Report (MMWR) updates the 2015–16 recommendations of Advisory Committee on Immunization Practices (ACIP) regarding use seasonal influenza vaccines.
In 2004, four recipients of kidneys, a liver, and an arterial segment from common organ donor died encephalitis unknown cause.We reviewed the medical records recipients. Blood, cerebrospinal fluid, tissues were tested with variety assays pathological stains for numerous causes encephalitis. Samples also inoculated into mice.The had been healthy before having subarachnoid hemorrhage that led to his death. Encephalitis developed in all within 30 days after transplantation was accompanied by...
This report from CDCâs Morbidity and Mortality Weekly Report (MMWR) replaces the 2007 Interim Pre-pandemic Planning Guidance: Community Strategy for Pandemic Influenza Mitigation in United States â Early, Targeted, Layered Use of Nonpharmaceutical Interventions.
To calculate the burden of 2009 pandemic influenza A (pH1N1) in United States, we extrapolated from Centers for Disease Control and Prevention's Emerging Infections Program laboratory-confirmed hospitalizations across entire then corrected underreporting. From 12 April to 10 2010, estimate that approximately 60.8 million cases (range: 43.3–89.3 million), 274 304 (195 086–402 719), 469 deaths (8868–18 306) occurred States due pH1N1. Eighty-seven percent those under 65 years age with children...
On December 31, 2019, Chinese health officials reported a cluster of cases acute respiratory illness in persons associated with the Hunan seafood and animal market city Wuhan, Hubei Province, central China. January 7, 2020, confirmed that novel coronavirus (2019-nCoV) was this initial (1). As February 4, total 20,471 cases, including 2,788 (13.6%) severe illness,* 425 deaths (2.1%) had been by National Health Commission China (2). Cases have also 26 locations outside mainland China,...
Abstract Acinetobacter infections have increased and gained attention because of the organism’s prolonged environmental survival propensity to develop antimicrobial drug resistance. The effect multidrug-resistant (MDR) infection on clinical outcomes has not been reported. A retrospective, matched cohort investigation was performed at 2 Baltimore hospitals examine patients with MDR compared susceptible without infections. Multivariable analysis controlling for severity illness underlying...
Abstract During the 2003–04 influenza season, 17 cases of Staphylococcus aureus community-acquired pneumonia (CAP) were reported from 9 states; 15 (88%) associated with methicillin-resistant S. (MRSA). The median age patients was 21 years; 5 (29%) had underlying diseases, and 4 (24%) risk factors for MRSA. Twelve (71%) laboratory evidence virus infection. All but 1 patient, who died on arrival, hospitalized. Death occurred in (4 MRSA). isolates available 13 (76%) (11 Toxin genes detected all...
This report updates the 2018-19 recommendations of Advisory Committee on Immunization Practices (ACIP) regarding use seasonal influenza vaccines in United States (MMWR Recomm Rep 2018;67[No. RR-3]). Routine annual vaccination is recommended for all persons aged ≥6 months who do not have contraindications. A licensed, recommended, and age-appropriate vaccine should be used. Inactivated (IIVs), recombinant (RIV), live attenuated (LAIV) are expected to available 2019-20 season. Standard-dose,...
This report updates the 2016-17 recommendations of Advisory Committee on Immunization Practices (ACIP) regarding use seasonal influenza vaccines (MMWR Recomm Rep 2016;65[No. RR-5]). Routine annual vaccination is recommended for all persons aged ≥6 months who do not have contraindications. A licensed, recommended, and age-appropriate vaccine should be used.For 2017-18 season, quadrivalent trivalent will available. Inactivated (IIVs) available in (IIV3) (IIV4) formulations. Recombinant (RIV)...
Through July 2009, a total of 43,677 laboratory-confirmed cases influenza A pandemic (H1N1) 2009 were reported in the United States, which is likely substantial underestimate true number. Correcting for under-ascertainment using multiplier model, we estimate that 1.8 million-5.7 million occurred, including 9,000-21,000 hospitalizations.
An outbreak of coronavirus disease 2019 (COVID-19) caused by the novel (SARS-CoV-2) began in Wuhan, Hubei Province, China December 2019, and has spread throughout to 31 other countries territories, including United States (1). As February 23, 2020, there were 76,936 reported cases mainland 1,875 locations outside There have been 2,462 associated deaths worldwide; no States. Fourteen diagnosed States, an additional 39 occurred among repatriated persons from high-risk settings, for a current...
During the 2015-16 influenza season (October 4, 2015-May 21, 2016) in United States, activity* was lower and peaked later compared with previous three seasons (2012-13, 2013-14, 2014-15). Activity remained low from October 2015 until late December mid-March 2016. most recent 18 (including this season), only two other have March (2011-12 2005-06). Overall activity moderate season, a percentage of outpatient visits for influenza-like illness (ILI),(†) hospitalization rates, deaths attributed...
with recommendations of AAFP, ACOG, and the American College Physicians (ACP).ACIP approved by CDC Director become agency guidelines on date published in Morbidity Mortality Weekly Report (MMWR).Additional information is available at https://www.cdc.gov/vaccines/acip.
Background Estimates of influenza disease burden are broadly useful for public health, helping national and local authorities monitor epidemiologic trends, plan allocate resources, promote vaccination. Historically, estimates the seasonal in United States, focused mainly on influenza‐related mortality hospitalization, were generated every few years. Since 2010‐2011 season, annual US have been expanded to include outpatient medical visits symptomatic illness community. Methods We used...
The United States 2017-18 influenza season (October 1, 2017-May 19, 2018) was a high severity with levels of outpatient clinic and emergency department visits for influenza-like illness (ILI), influenza-related hospitalization rates, elevated geographically widespread activity across the country an extended period. Nationally, ILI began increasing in November, reaching period during January-February, remaining through March. Influenza A(H3N2) viruses predominated February were predominant...